The Scientist - Home

At least 5,000 of the country’s researchers have published their work on questionable platforms, often forking over exorbitant fees, a report finds.

A pesticide industry leader, Hutchins was formerly president of the Entomological Society of America.

Opponents of the guidelines, which would bar results of many public health studies from use in policy making, include scientific and healthcare organizations.

Researchers silence pain neurons in the mouse spinal cord with injections of botulinum toxins modified to bind to the neurons’ receptors.

Compared to other drugs, therapeutics given breakthrough status receive FDA approval on the basis of weaker trial evidence, a study finds.

Accusations that Nazneen Rahman bullied employees at the Institute of Cancer Research in the U.K. stretch back 12 years.

The UK-based organization encourages public debate about the issue but does not recommend immediate policy change.

The adoption of machine-learning techniques to aid in diagnosis should be done with radiologists’ guidance.

Richard Vogt, this year’s awardee, showed inappropriate images of researchers in the field during his acceptance speech.

Female PIs apply for fewer grants, but retain support once they get it.

The DNA-cutting enzyme used in the technique is not as precisely targeted as scientists had thought, and investors take notice.

Researchers use a combination of ultrasound waves, genetic engineering, and synthetic drugs to switch specific neurons on and off in mice.